Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
23.30 EUR | +0.43% | +6.88% | -52.74% |
09-10 | Four steps back, one step forward | |
09-10 | Delfingen: share price falls, half-year results down | CF |
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Revenues | 230M | 242M | 363M | 417M | 457M | |||||
Other Revenues, Total | - | - | - | - | - | |||||
Total Revenues | 230M | 242M | 363M | 417M | 457M | |||||
Cost of Goods Sold, Total | 133M | 134M | 223M | 275M | 285M | |||||
Gross Profit | 97.27M | 108M | 140M | 142M | 171M | |||||
Selling General & Admin Expenses, Total | 68.56M | 72.06M | 93.49M | 101M | 122M | |||||
Depreciation & Amortization - (IS) | 12.37M | 14.48M | 18.43M | 19.95M | 21.2M | |||||
Other Operating Expenses | 1.1M | 479K | 3.08M | 3.45M | 3.02M | |||||
Other Operating Expenses, Total | 82.03M | 87.02M | 115M | 124M | 146M | |||||
Operating Income | 15.24M | 20.88M | 24.8M | 17.42M | 25.49M | |||||
Interest Expense, Total | -2.99M | -3.11M | -3.79M | -3.52M | -8.02M | |||||
Interest And Investment Income | 19K | 13K | 60K | 11K | 33K | |||||
Net Interest Expenses | -2.97M | -3.1M | -3.73M | -3.5M | -7.98M | |||||
Currency Exchange Gains (Loss) | -815K | -1.2M | 547K | -138K | -1.36M | |||||
Other Non Operating Income (Expenses) | 29K | -16K | 254K | 68K | -222K | |||||
EBT, Excl. Unusual Items | 11.48M | 16.57M | 21.88M | 13.85M | 15.92M | |||||
Restructuring Charges | - | - | - | - | - | |||||
Merger & Related Restructuring Charges | - | -2.1M | - | - | -800K | |||||
Impairment of Goodwill | - | -882K | - | - | - | |||||
Gain (Loss) On Sale Of Investments | - | - | -212K | - | -168K | |||||
Gain (Loss) On Sale Of Assets | 194K | -1.05M | -193K | -52K | -749K | |||||
Asset Writedown | -75K | -131K | -163K | 379K | 71K | |||||
Legal Settlements | - | - | - | - | - | |||||
Other Unusual Items | - | 37.1M | - | - | - | |||||
EBT, Incl. Unusual Items | 11.6M | 49.5M | 21.31M | 14.17M | 14.28M | |||||
Income Tax Expense | 3.07M | 4.05M | 4.95M | 5.91M | 7.25M | |||||
Earnings From Continuing Operations | 8.53M | 45.46M | 16.36M | 8.27M | 7.03M | |||||
Earnings Of Discontinued Operations | - | - | - | - | - | |||||
Net Income to Company | 8.53M | 45.46M | 16.36M | 8.27M | 7.03M | |||||
Minority Interest | 1K | -149K | -233K | -122K | -122K | |||||
Net Income - (IS) | 8.53M | 45.31M | 16.13M | 8.14M | 6.9M | |||||
Net Income to Common Incl Extra Items | 8.53M | 45.31M | 16.13M | 8.14M | 6.9M | |||||
Net Income to Common Excl. Extra Items | 8.53M | 45.31M | 16.13M | 8.14M | 6.9M | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 3.54 | 18.67 | 6.14 | 3.11 | 2.64 | |||||
Basic EPS - Continuing Operations | 3.54 | 18.67 | 6.14 | 3.11 | 2.64 | |||||
Basic Weighted Average Shares Outstanding | 2.41M | 2.43M | 2.62M | 2.62M | 2.62M | |||||
Net EPS - Diluted | 3.54 | 18.67 | 6.14 | 3.11 | 2.64 | |||||
Diluted EPS - Continuing Operations | 3.54 | 18.67 | 6.14 | 3.11 | 2.64 | |||||
Diluted Weighted Average Shares Outstanding | 2.41M | 2.43M | 2.62M | 2.62M | 2.62M | |||||
Normalized Basic EPS | 2.98 | 4.2 | 5.12 | 3.26 | 3.76 | |||||
Normalized Diluted EPS | 2.98 | 4.2 | 5.12 | 3.26 | 3.76 | |||||
Dividend Per Share | - | 0.38 | 1.13 | 0.64 | 1.15 | |||||
Payout Ratio | 16.06 | - | 6.2 | 36.24 | 24.23 | |||||
Supplemental Items | ||||||||||
EBITDA | 22.28M | 34.33M | 41.25M | 34.83M | 44.5M | |||||
EBITA | 16M | 22.03M | 26.02M | 18.8M | 26.98M | |||||
EBIT | 15.24M | 20.88M | 24.8M | 17.42M | 25.49M | |||||
EBITDAR | 24.29M | 36.83M | 44.99M | 39.2M | 49.9M | |||||
Total Revenues (As Reported) | 231M | 242M | 363M | 418M | 457M | |||||
Effective Tax Rate - (Ratio) | 26.48 | 8.18 | 23.23 | 41.67 | 50.78 | |||||
Total Current Taxes | 2.82M | 4.28M | 5.15M | 6.77M | 8.24M | |||||
Total Deferred Taxes | 252K | -236K | -197K | -865K | -989K | |||||
Normalized Net Income | 7.18M | 10.2M | 13.44M | 8.53M | 9.83M | |||||
Interest on Long-Term Debt | 400K | - | - | - | - | |||||
Supplemental Operating Expense Items | ||||||||||
Research And Development Expense From Footnotes | 329K | 686K | 1.64M | 1.58M | 1.1M | |||||
Net Rental Expense, Total | 2.01M | 2.5M | 3.75M | 4.36M | 5.39M | |||||
Imputed Operating Lease Interest Expense | 656K | 589K | 875K | 897K | 2.22M | |||||
Imputed Operating Lease Depreciation | 1.35M | 1.91M | 2.87M | 3.47M | 3.17M | |||||
Maintenance & Repair Expenses, Total | 3.96M | 4.21M | 6.3M | 6.68M | 8.14M |